HPV

HPV is the name given to a very common group of viruses.

There are many types of HPV, some of which are called "high risk" because they're linked to the development of cancers, such as cervical cancer, anal cancer, genital cancers, and cancers of the head and neck.

Other types can cause conditions like warts or verrucas.

Nearly all cervical cancers (99.7%) are caused by infection with a high-risk type of HPV.

But only some of the anal and genital cancers, and cancers of the head and neck, are caused by HPV infection.

The rest of these cancers are caused by other risk factors like smoking and drinking alcohol.

HPV infections do not usually cause any symptoms, and most people will not know they're infected.

Find out more about HPV

What are the different types of HPV and what do they do?

There are more than 100 different types of HPV, and around 40 that affect the genital area.

HPV is very common and can be caught through any kind of sexual contact with another person who already has it.

Most people will get an HPV infection at some point in their lives and their bodies will get rid of it naturally without treatment.

But some people infected with a high-risk type of HPV will not be able to clear it.

Over time, this can cause abnormal tissue growth as well as other changes, which can lead to cancer if not treated.

High-risk types of HPV are linked to different types of cancer, including:

Infection with other types of HPV may cause:

  • genital warts – small growths or skin changes on or around the genital or anal area; they're the most common viral sexually transmitted infection (STI) in the UK 
  • skin warts and verrucas – not on the genital area
  • warts on the voice box or vocal cords (laryngeal papillomas)

How does the HPV vaccine work?

Currently, the national NHS HPV vaccination programme uses a vaccine called Gardasil.

Gardasil protects against 4 types of HPV: 6, 11, 16 and 18. Between them, types 16 and 18 are the cause of most cervical cancers in the UK (more than 70%).

These types of HPV also cause some anal and genital cancers, and some cancers of the head and neck.

HPV types 6 and 11 cause around 90% of genital warts, so using Gardasil helps protect girls against both cervical cancer and genital warts.

HPV vaccination does not protect against other infections spread during sex, such as chlamydia, and it will not stop girls getting pregnant, so it's still very important to practise safe sex.

Who can have the HPV vaccine through the NHS vaccination programme?

From September 2019, the first dose of the HPV vaccine will be routinely offered to girls and boys aged 12 and 13 in school Year 8.

The second dose is normally offered 6 to 12 months after the first (in school Year 8 or Year 9).

People who miss either of their HPV vaccine doses should speak to their school immunisation team or GP surgery and make an appointment to get up-to-date as soon as possible.

It's important to have both doses of the vaccine to be fully protected.

People who were eligible for HPV vaccination in school Year 8 but who missed it can still be vaccinated on the NHS up to their 25th birthday.

People who start the HPV vaccination after the age of 15 will need 3 doses as they do not respond as well to 2 doses as younger people do.

Find out more about who can have the HPV vaccine

Read more about HPV vaccination safety and the possible side effects.

How is the HPV vaccination programme changing?

In July 2018, it was announced that the HPV vaccine would be extended to boys aged 12 to 13 years in England.

This decision was based on advice from the Joint Committee on Vaccination and Immunisation (JCVI), the independent body that advises UK health departments on immunisation.

From the 2019-20 school year, 12- to 13-year-old boys and girls in school Year 8 will both be eligible for the HPV vaccine.

This extension of the HPV vaccination programme will help prevent more cases of HPV-related cancers in boys and girls, such as head and neck cancers and anal and genital cancers.

A catch-up programme for older boys is not necessary as evidence suggests they're already benefiting greatly from the indirect protection (known as herd protection) that's built up from 10 years of the girls' HPV vaccination programme.

The priority is to make sure that as many eligible boys and girls as possible are offered protection against HPV infection from the 2019-20 school year.